Table 5.

Patients suspected of coronavirus disease-2019

Attendance at a hospital (n = 9)	Rheumatic disease	Disease duration (mo)	Comorbid diseases	Current treatment	BCG status	Treatment interruption	Symptoms	Contact history	Chest X -ray (n = 6)	CT (n = 4)	PCR (n = 9)	Confirmed diagnosis
15-y M	oJIA + FMF	41	_	Methotrexate, Etanercept, Colchicium	Neg	No	Asymptomatic	Mother	_	_	Neg	No
16-y M	ERA + FMF	85	_	Adalimumab, Colchicium	Pos	No	Fever,arthralgia,myalgia	No	Normal	Normal	Neg	No
11-y M	SoJIA	54	_	Tocilizumab	Pos	No	Asymptomatic	Cousin	Normal	_	Neg	No
16-y F	RF + PoJIA + FMF	90	_	Abatacept, Leflunomide	Pos	No	Cough	No	Normal	_	Neg	No
17-y M	ERA	64	_	Adalimumab	Pos	No	Fever, sore throat	Father	Normal	Normal	Neg	No
14-y F	RF-PoJIA	9	_	Leflunomide	Pos	No	Fever,cough,fatigue, anosmia,dysgeusia	Father, uncle	Suspicious infiltrates	Ground glass opacity + consolidation	Pos	Yes
13-y F	FMF	77	_	Canakinumab	Pos	Yes*	Fever, arthralgia	No	_	_	Neg	No
10-y M	CAPS	89	_	Canakinumab	Pos	No	Arthralgia	Mother	_	_	Neg	No
12-y F	FMF	78	_	Canakinumab	Pos	Yes*	Asymptomatic	Father,brother	Normal	Normal	Neg	No

*Inadequate access to health care. BCG Bacillus Calmette-Guerin, CT Computed tomography, PCR Pharyngeal swab COVID-19 nucleic acid test, oJIA Oligoarthrtitis juvenile idiopathic arthritis, FMF Familial mediterranean fever, Enthesitis-related arthritis, SoJIA Systemic-onset arthritis, RF + PoJIA Rheumatoid factor -positive polyarthritis, RF- PoJIA RF-negative polyarthritis, CAPS Cryopyrin-associated periodic syndrome, neg negative, pos positive